Year: 2013
Type: review
Abstract: Autism spectrum disorders (ASD) encompass a range of neurodevelopmental conditions that are clinically and etiologically very heterogeneous. ASD is currently diagnosed entirely on behavioral criteria, but intensive research efforts are focused on identifying biological markers for disease risk and early diagnosis. Here, we discuss recent progress toward identifying biological markers for ASD and highlight specific challenges as well as ethical aspects of translating ASD biomarker research into the clinic.
Source: Disease Markers
DOI: 10.1155/2013/476276
Authors: Irina Voineagu, Hee Jeong Yoo
Institutions: UNSW Sydney, Seoul National University Bundang Hospital
Language: English
Subfield: Cognitive Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $2,550
Awards: G1820235269, G619565984
OpenAlex ID: W2105753492
